$1.79
+0.04 (+2.29%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+474.3% upside
Low Target
$7.14
Average Target
$10.28
High Target
$13.13
Current Price
$1.79
Current
$1.79
$1.79
Target
$10.28
$10.28
$7.14
$10.28 avg
$13.13
Scenario Analysis
Bear Case
$7.14
298.9%
Low target
Base Case
$10.28
+474.3%
Avg target
Bull Case
$13.13
+633.5%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$9.63
-81.4% from high
52-Week Low
$6.30
+-71.6% from low
Target vs 52W High
$10.28
+6.7% vs high
Next Earnings Report
Feb 26, 2026 · After Market Close
10d
until earnings
EPS Est: $-0.33
Earnings in 10 days. Analyst targets may shift significantly after the report.
Peer Consensus — Life Sciences Tools & Services
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| TMO | Strong Buy | 33 | 82% | $369.21 | -32.0% |
| DHR | Strong Buy | 31 | 87% | $158.11 | -27.0% |
| A | Buy | 29 | 72% | $64.69 | -50.1% |
| IQV | Strong Buy | 30 | 80% | $82.96 | -55.8% |
| MTD | Hold | 21 | 43% | $170.43 | -87.6% |
| WAT | Buy | 25 | 56% | $189.60 | -50.3% |
| ILMN | Hold | 26 | 50% | $169.36 | +41.5% |
| WST | Strong Buy | 23 | 78% | $136.24 | -45.3% |